Consolidated Statement Of Cash Flows

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7270730

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
565,000,000 JPY
829,000,000 JPY
-3,689,000,000 JPY
-3,563,000,000 JPY
Depreciation
256,000,000 JPY
704,000,000 JPY
Impairment losses
239,000,000 JPY
2,502,000,000 JPY
Interest and dividend income
-30,000,000 JPY
-25,000,000 JPY
Interest expenses
8,000,000 JPY
8,000,000 JPY
Increase (decrease) in provision for bonuses
100,000,000 JPY
51,000,000 JPY
Increase (decrease) in retirement benefit liability
31,000,000 JPY
-34,000,000 JPY
Foreign exchange losses (gains)
0 JPY
0 JPY
Decrease (increase) in trade receivables
-411,000,000 JPY
-175,000,000 JPY
Subtotal
168,000,000 JPY
282,000,000 JPY
Decrease (increase) in inventories
-301,000,000 JPY
581,000,000 JPY
Income taxes paid
-30,000,000 JPY
0 JPY
Increase (decrease) in trade payables
-76,000,000 JPY
78,000,000 JPY
Net cash provided by (used in) operating activities
362,000,000 JPY
-307,000,000 JPY
Other, net
47,000,000 JPY
0 JPY
Interest and dividends received
32,000,000 JPY
25,000,000 JPY
Loss (gain) on sale of non-current assets
JPY
-76,000,000 JPY
Interest paid
-8,000,000 JPY
-8,000,000 JPY
Cash flows from investing activities
Payments into time deposits
-49,000,000 JPY
-22,000,000 JPY
Proceeds from withdrawal of time deposits
304,000,000 JPY
106,000,000 JPY
Purchase of property, plant and equipment
-157,000,000 JPY
-97,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
170,000,000 JPY
Net cash provided by (used in) investing activities
-5,000,000 JPY
1,166,000,000 JPY
Proceeds from sale of investment securities
11,000,000 JPY
621,000,000 JPY
Other, net
0 JPY
5,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-1,000,000 JPY
-1,000,000 JPY
Proceeds from long-term borrowings
JPY
500,000,000 JPY
Repayments of long-term borrowings
-1,206,000,000 JPY
-1,053,000,000 JPY
Net cash provided by (used in) financing activities
-1,181,000,000 JPY
1,539,000,000 JPY
Repayments of lease liabilities
-28,000,000 JPY
-33,000,000 JPY
Other, net
-4,000,000 JPY
-4,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
112,000,000 JPY
49,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-712,000,000 JPY
2,447,000,000 JPY
Cash and cash equivalents
4,532,000,000 JPY
5,244,000,000 JPY
2,797,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.